First Light Asset Management, LLC is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.
Filed | Shares | Percentage | |
---|---|---|---|
REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
VAPOTHERM INC | February 14, 2020 | 933,117 | 4.4% |
HARVARD BIOSCIENCE INC | July 03, 2019 | 588,148 | 1.6% |
STREAMLINE HEALTH SOLUTIONS INC.Sold out | February 14, 2019 | 0 | 0.0% |
TANDEM DIABETES CARE INC | June 11, 2018 | 2,042,188 | 4.1% |
TearLab CorpSold out | May 11, 2018 | 0 | 0.0% |
NEOGENOMICS INC | February 14, 2017 | 2,573,891 | 3.3% |